Switching from Tobacco to E-Cigarettes Could Improve Vascular Health
Results of the VESUVIUS trial are adding fuel to the fire in the debate over the impact of electronic cigarettes in former tobacco users.
Results of the VESUVIUS trial are adding fuel to the fire in the debate over the impact of electronic cigarettes in former tobacco users.
In this episode, hosts explore promising results of orforglipron, a new oral GLP-1 receptor agonist, showing significant A1C reduction and weight loss potential.
Findings suggest frequent consumption of non-skimmed milk may heighten the risk of developing MAFLD.
In this analysis, investigators compared older and younger patients with psoriasis in terms of drug survival and other results of biologic medications.
HCPLive is a clinical news and information portal, offering physicians specialty and disease-specific resources, conference coverage, and interviews.
Evaluate efficacy and show safety results of Risankizumab vs Ustekinumab for the treatment of moderate-to-severe Crohn’s Disease. Explore the study design and outcomes of Risankizumab’s…
Watch expert panelists share perspectives on real patient cases to help fellow clinicians better understand and recognize hypercortisolism. Watch expert panelists share perspectives on real…
These phase 2a data on IMG-007, a nondepleting anti-OX40 monoclonal antibody, highlight its efficacy among those with alopecia areata.
Ten percent of effector genes identified express proteins targeted by approved drugs across disease fields.
Real-world data show omalizumab, alone or with OIT, is effective and well-tolerated for IgE-mediated food allergy, with high response rates in adults.
These data highlight the risk level among certain patients with psoriasis of excessive sun exposure, associated commonly with tanning.